Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1981 Dec;12(6):771-7.
doi: 10.1111/j.1365-2125.1981.tb01305.x.

Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man

Comparative Study

Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man

A R Boobis et al. Br J Clin Pharmacol. 1981 Dec.

Abstract

1 The metabolism of antipyrine to its three main oxidative metabolites, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norphenazone was investigated in vivo and in vitro in separate groups of subjects with normal hepatic function and in the same group of patients with suspected liver disease. 2 The rank order for the rate of formation of the three metabolites of antipyrine was similar in vivo and in vitro. 3 There was no significant correlation between the rates of formation of any pair of antipyrine metabolites either in vivo or in vitro. 4 Despite this there was a significant correlation between the in vivo and in vitro rates for formation of each of the three metabolites in the same group of patients. 5 It is concluded that determination of rates of formation of antipyrine metabolites from their excretion in urine provides an indication of the activity of the enzymes involved in their formation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1968 Jul 5;161(3836):72-3 - PubMed
    1. Br J Clin Pharmacol. 1980 Jan;9(1):11-9 - PubMed
    1. J Pharm Pharmacol. 1973 Mar;25(3):205-7 - PubMed
    1. Br J Clin Pharmacol. 1980 Mar;9(3):284P - PubMed
    1. Drug Metab Dispos. 1980 Jul-Aug;8(4):218-22 - PubMed

Publication types

LinkOut - more resources